Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Health behavior change plan for adults with metabolic syndrome and kidney disease

Official title: The Effectiveness of a Theory-based Health Behaviour Change Intervention on Waist Circumference and Kidney Function in Patients of Metabolic Syndrome With Chronic Kidney Disease: A Pilot Randomised Controlled Trial

Run by Chinese University of Hong Kong · NCT06527768 · Data updated 2026-11-12

A 40-person study will test a theory-based behavior-change program to see if it can reduce waist size and protect kidney function over three months in Chinese adults with metabolic syndrome and chronic kidney disease.

More Metabolic Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedJuly 31, 2024
Main results expectedJuly 31, 2026
Study endsJuly 31, 2026
Registry record updatedJune 11, 2026
Trial IDNCT06527768 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Chinese adults 18+ with both MetS (per IDF criteria) and CKD, who can walk briskly, own a smartphone, and reside in Chengdu during the study.

Probably not a fit

Patients with very advanced kidney disease or those unable to participate in walking exercise may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study uses a two-arm, randomized design to compare a theory-based health behavior change intervention with usual care. Participants are adults with metabolic syndrome and chronic kidney disease, recruited in Chengdu, China. The primary outcome is change in waist circumference and kidney function (estimated GFR and urine albumin-to-creatinine ratio) over three months, with secondary measures including dietary behavior, physical activity, exercise capacity, and self-efficacy. Assessors are blinded to group assignment, and data are collected at baseline and after the intervention. A total of 40 participants (20 per arm) will be enrolled to assess feasibility and acceptability in addition to preliminary effectiveness.

Why it matters

Potential benefit: If successful, the program could help reduce central obesity and preserve kidney function in this high-risk population.

How similar studies have gone: Previous work suggests behavior-change interventions can improve health behaviors; this study tests a theory-based approach specifically in MetS with CKD, which remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants are 18 years old and above;
* Participants have both diagnoses of MetS based on IDF clinical diagnostic criteria (WC for Chinese: ≥ 90 cm in men and ≥ 80 cm in women, and fulfils two items of the following: TG ≥ 1.7 mmol/L or treatment for hypertriglycerides, HDL-C\<1.03 mmol/L in men or \<1.29 mmol/L in women or treatment for low HDL-C, FG ≥5.6 mmol/L or previously diagnosed type 2 diabetes, and BP ≥ 130/85 mmHg or treatment for hypertension) and CKD;
* No medical contraindications to exercise, including walking;
* Participants are capable of understanding and providing informed consent;
* Own a smartphone for accessing WeChat;
* Being able to communicate in Chinese;
* Stay in Chengdu during the study period.

Exclusion Criteria:

* Participants who cannot perform brisk walking exercise;
* Participants who have already started dialysis or kidney transplant;
* Current participation in another clinical trial related to health behaviour change or medical trial;
* Participants who have doctor-diagnosed psychiatric illness;
* Participants who have a cognitive impairment, which will be screened by the abbreviated mental test with a score lower than seven;
* Adjustment of medication within half a year;
* Participants who have performed regular planned exercise (Defined as at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of high-intensity aerobic activity per week, or a combination of moderate-intensity and high-intensity aerobic activity) within the past month.

Where it's running

  • West China Hospital of Sichuan University
    Chengdu, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.